2007
DOI: 10.1016/j.bmc.2007.06.050
|View full text |Cite
|
Sign up to set email alerts
|

Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(12 citation statements)
references
References 34 publications
0
12
0
Order By: Relevance
“…It has been reported previously that (+)-digoxin ( 1 ) inhibits potently Na + /K + -ATPase activity, and the substituents at C-10, C-12, and C-17 of the steroid core of 1 or other cardiac glycosides could affect critically this enzyme inhibitory effect . Thus, the cytotoxic (+)-digoxin ( 1 ) and its noncytotoxic analogue, (+)-17- epi -20,22-dihydro-21α-hydroxydigoxin ( 7 ), were tested for their ability to inhibit Na + /K + -ATPase activity herein.…”
Section: Results and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been reported previously that (+)-digoxin ( 1 ) inhibits potently Na + /K + -ATPase activity, and the substituents at C-10, C-12, and C-17 of the steroid core of 1 or other cardiac glycosides could affect critically this enzyme inhibitory effect . Thus, the cytotoxic (+)-digoxin ( 1 ) and its noncytotoxic analogue, (+)-17- epi -20,22-dihydro-21α-hydroxydigoxin ( 7 ), were tested for their ability to inhibit Na + /K + -ATPase activity herein.…”
Section: Results and Discussionmentioning
confidence: 99%
“…It has been reported previously that (+)-digoxin (1) inhibits potently Na + /K + -ATPase activity, 42 and the substituents at C-10, C-12, and C-17 of the steroid core of 1 or other cardiac glycosides could affect critically this enzyme inhibitory effect. 43 Thus, the cytotoxic (+)-digoxin (1) and its noncytotoxic analogue, (+)-17-epi-20,22-dihydro-21α-hydroxydigoxin (7), were tested for their ability to inhibit Na + /K + -ATPase activity herein. The cellular enzyme adenosine 5′-triphosphatase from the porcine cerebral cortex was treated with various concentrations of both cardiac glycosides, and, as expected, 1 inhibited Na + /K + -ATPase activity in a concentration-dependent manner, with an IC 50 value of 0.23 μM (Figure 2C), but 7 did not at concentrations less than 100 μM (IC 50 160.2 μM) (Figure 2D), indicating that the cytotoxicity of 1 could result from its Na + /K + -ATPase inhibitory activity.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…71 The primary instance of a nine-membered chain (a−i) occurs in the C and D rings of the steroidal nucleus and an additional occurrence of such a nine-membered chain (j−r) can also be observed in some compounds such as 11. Another important feature for the activity of cardiac glycosides indicated by Stanton et al 69 as well as Paula et al 72 is the cis−trans stereochemistry of bonds C5−C10 and C13−C14, connecting rings A and B and C and D, respectively. A cis fusion of the rings at either or both the bonds can be more favorable to the activity than the transfusion.…”
Section: Nonglycoside Inhibitorsmentioning
confidence: 98%
“…These authors proposed that binding of cardiac glycoside occurs in two steps: first binding of the steroid and then a slower interaction of the sugar residues. 67,68 In a recent study, Stanton et al 69 reported that the nature of substituent at the 17β-position is an important determinant of the activity. In most active glycosides, it is a monounsaturated five-membered furanone.…”
Section: Nonglycoside Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation